NCT03571555

Brief Summary

Adolescents/young adults with perinatally acquired HIV (PAH) face a number of antiretroviral (ART) adherence and well-being challenges. Two psychosocial interventions that have been developed to address a range of needs of this population (and their caregivers) are residential interventions (camps) and support groups (clubs). There has been little quantitative evaluation of the effects of attending camps for young people and clubs (for children or caregivers), globally. This study aims to investigate whether a package of psychosocial support (camps and clubs) offered to young people living with HIV and their caregivers in Botswana by the Sentebale organisation, is associated with improvements in psychological, behavioural and clinical outcomes from first attendance to one year follow-up. In addition, the study will explore how the psychosocial programme is experienced by young people and their caregivers, and what the perceived impact is. The project as a whole will take place over three years. There will be an initial six month preparatory phase that will include the adaptation of self-report measures for the study context. Subsequently, two studies will be undertaken. The main study will involve a single group within-participants prospective cohort design with two time points (baseline and one year follow-up) with young people and caregivers. The sub-study will involve a qualitative cross sectional design involving semi-structured interviews with young people and caregivers. Young people will be eligible to participate if they are aged 10 to 19 years at the time of study enrolment, are living with HIV and aware of HIV-positive status, have recently started attending the Sentebale programme, and are able to give informed assent/consent. We will aim to retain 175 young people (of 253 recruited) . We will also aim to retain 178 caregivers (of 263 recruited). The sample size for the sub-study will consist of ten young people and ten caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
516

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 27, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
10 months until next milestone

Results Posted

Study results publicly available

April 26, 2021

Completed
Last Updated

April 26, 2021

Status Verified

March 1, 2021

Enrollment Period

1.3 years

First QC Date

May 31, 2018

Results QC Date

March 27, 2021

Last Update Submit

March 27, 2021

Conditions

Keywords

HIVperinataladolescentcamppsychosocial

Outcome Measures

Primary Outcomes (1)

  • Quality of Life/Well-being (Young People)

    The 17 item Pediatric Symptom Checklist (PSY-Y-17) will be used. Minimum value 0, maximum 51. Higher scores, worse outcome.

    One year

Secondary Outcomes (18)

  • HIV Knowledge (Young People)

    One year

  • HIV Adjustment (Young People)

    One year

  • ART Adherence Behaviour (Young People)

    One year

  • ART Adherence Attitudes (Young People)

    One year

  • ART Adherence Self-efficacy (Young People)

    One year

  • +13 more secondary outcomes

Study Arms (2)

Young people with perinatally acquired HIV

Residential interventions (camps) and community based support (clubs)

Behavioral: Sentebale Psychosocial Programme

Caregivers of young people with perinatally acquired HIV

Community based support (clubs)

Behavioral: Sentebale Psychosocial Programme

Interventions

Residential interventions (camps) for the young people, and community based support (clubs) for the young people and the caregivers.

Caregivers of young people with perinatally acquired HIVYoung people with perinatally acquired HIV

Eligibility Criteria

Age10 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

10-19 year olds living with HIV, new attenders to the Sentebale psychosocial programme Primary caregivers of 10-19 year olds living with HIV attending Sentebale, who are also attending Sentebale themselves

You may qualify if:

  • Aged 10 to 19 years at the time of study enrolment
  • Living with HIV and aware of HIV-positive status
  • Able to give informed consent if 18 or 19 years
  • Able to give informed assent if 10-17 years
  • Presence of a caregiver to give caregiver consent if 10-17 years
  • Attending Sentebale clubs with first attendance at club within previous month

You may not qualify if:

  • Previous camp attendance
  • Any attendance at a different club/organisation providing a similar function
  • Planning to leave the area served by the club within the next year
  • CAREGIVERS
  • Primary caregiver for a young person attending Sentebale
  • Able to give informed consent
  • Attending Sentebale clubs with first attendance within previous month
  • Any attendance at a different club/organisation providing a similar function
  • Planning to leave the area served by the club within the next year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sentebale

Gaborone, Botswana

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeMuscle Cramp

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Michael Evangeli
Organization
Royal Holloway University of London

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 31, 2018

First Posted

June 27, 2018

Study Start

March 1, 2019

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

April 26, 2021

Results First Posted

April 26, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share

Anonymised electronic data from the study will be transferred to a data repository (eg.,Figshare or RHUL Research Data Archive) at the end of the study.

Shared Documents
STUDY PROTOCOL
Time Frame
At the end of the study. For 10 years.

Locations